238 related articles for article (PubMed ID: 17440009)
1. Argatroban anticoagulation in critically ill patients.
Beiderlinden M; Treschan TA; Görlinger K; Peters J
Ann Pharmacother; 2007 May; 41(5):749-54. PubMed ID: 17440009
[TBL] [Abstract][Full Text] [Related]
2. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
Saugel B; Phillip V; Moessmer G; Schmid RM; Huber W
Crit Care; 2010; 14(3):R90. PubMed ID: 20487559
[TBL] [Abstract][Full Text] [Related]
3. Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.
Keegan SP; Gallagher EM; Ernst NE; Young EJ; Mueller EW
Ann Pharmacother; 2009 Jan; 43(1):19-27. PubMed ID: 19116377
[TBL] [Abstract][Full Text] [Related]
4. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
[TBL] [Abstract][Full Text] [Related]
5. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
Bartholomew JR; Pietrangeli CE; Hursting MJ
Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
[TBL] [Abstract][Full Text] [Related]
6. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
Guzzi LM; McCollum DA; Hursting MJ
J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
[TBL] [Abstract][Full Text] [Related]
7. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
Levine RL; Hursting MJ; McCollum D
Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
Hursting MJ; Verme-Gibboney CN
J Cardiovasc Pharmacol; 2008 Dec; 52(6):561-6. PubMed ID: 19057393
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.
Vo QA; Lin JK; Tong LM
Ann Pharmacother; 2015 Feb; 49(2):178-84. PubMed ID: 25515865
[TBL] [Abstract][Full Text] [Related]
10. Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.
Ansara AJ; Arif S; Warhurst RD
Ann Pharmacother; 2009 Jan; 43(1):9-18. PubMed ID: 19126826
[TBL] [Abstract][Full Text] [Related]
11. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
Shapiro NL; Durr EA; Krueger CD
Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
[TBL] [Abstract][Full Text] [Related]
12. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
[TBL] [Abstract][Full Text] [Related]
13. Argatroban in extracorporeal membrane oxygenation.
Beiderlinden M; Treschan T; Görlinger K; Peters J
Artif Organs; 2007 Jun; 31(6):461-5. PubMed ID: 17537058
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
Bain J; Meyer A
Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889
[TBL] [Abstract][Full Text] [Related]
15. Argatroban anticoagulation in intensive care patients: effects of heart failure and multiple organ system failure.
Begelman SM; Baghdasarian SB; Singh IM; Militello MA; Hursting MJ; Bartholomew JR
J Intensive Care Med; 2008; 23(5):313-20. PubMed ID: 18701526
[TBL] [Abstract][Full Text] [Related]
16. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of argatroban in critically ill patients with heparin resistance: a retrospective analysis.
Treichl B; Bachler M; Lorenz I; Friesenecker B; Oswald E; Schlimp CJ; Pedross F; Fries D
Semin Thromb Hemost; 2015 Feb; 41(1):61-7. PubMed ID: 25594496
[TBL] [Abstract][Full Text] [Related]
18. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Dager WE; White RH
Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
[TBL] [Abstract][Full Text] [Related]
19. Extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer.
Kubiak DW; Szumita PM; Fanikos JR
Ann Pharmacother; 2005 Jun; 39(6):1119-23. PubMed ID: 15886289
[TBL] [Abstract][Full Text] [Related]
20. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Berkowitz SD; Matthai WH; Fareed J; Walenga JM; Bartholomew J; Sham R; Lerner RG; Zeigler ZR; Rustagi PK; Jang IK; Rifkin SD; Moran J; Hursting MJ; Kelton JG;
Circulation; 2001 Apr; 103(14):1838-43. PubMed ID: 11294800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
